Theravance Biopharma (TBPH) Change in Taxes (2014 - 2025)

Theravance Biopharma's (TBPH) quarterly Change in Taxes came in at -$22.6 million in Q3 2025, down 605.75% on a QoQ basis from $4.5 million in Q1 2018.

Theravance Biopharma (TBPH) Change in Taxes (2014 - 2025) Analysis & Trends

Theravance Biopharma (TBPH) has 6 years of Change in Taxes data on file, last reported at -$22.6 million in Q3 2025.

  • On a quarterly basis, Change in Taxes changed N/A year-over-year to -$22.6 million in Q3 2025; TTM through Sep 2025 was -$21.1 million, a N/A change from a year earlier, with the FY2017 full-year figure at -$2.8 million, up 70.72% from the prior year.
  • Change in Taxes for Q3 2025 stood at -$22.6 million, down from $4.5 million in the prior quarter.
  • Over the last five years, Change in Taxes for TBPH reached as high as -$22.6 million in Q3 2025 and fell as low as -$22.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -8,939.03
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Theravance Biopharma 864.82 Mn 470.15 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -22.62 Mn
Sep 30, 2025 -22.62 Mn
Mar 31, 2018 4.47 Mn
Mar 31, 2018 4.47 Mn
Sep 30, 2017 -3.00 Mn
Sep 30, 2017 -3.00 Mn
Jun 30, 2017 212,000.00
Jun 30, 2017 212,000.00
Dec 31, 2016 74,000.00
Dec 31, 2016 74,000.00
Sep 30, 2016 18,000.00
Sep 30, 2016 18,000.00
Jun 30, 2016 2.91 Mn
Jun 30, 2016 2.91 Mn
Mar 31, 2016 -12.52 Mn
Mar 31, 2016 -12.52 Mn
Dec 31, 2015 11.46 Mn
Dec 31, 2015 11.46 Mn
Sep 30, 2015 -1.72 Mn
Sep 30, 2015 -1.72 Mn